Gut Microbiota in Health and Disease: Insights from the Latest Research in Mexico City
The 4th International Symposium on Gut Microbiota in Health and Disease was a success this year, with 946 attendees - more than a third higher than last year.
The 4th International Symposium on Gut Microbiota in Health and Disease was a success this year, with 946 attendees – more than a third higher than last year. Doctors, nutritionists, and other healthcare professionals came to hear the latest research on the importance of the gut microbiota composition through the lifespan, the role of the microbiota in different diseases, and different therapeutic tools such as probiotics and fecal microbiota transplantation.
The event was focused on state-of-the-art clinical applications, so speakers discussed ways to manipulate the microbiota and correct dysbiosis. Scientific evidence was presented on the use of dietary interventions and probiotics in different diseases, as well as the effectiveness and risks of fecal microbiota transplantation.
The speakers – seven from Mexico and two from the international community, follow this link to read Elena Verdú’s report from the event – addressed a full house on both days (Friday, May 29th and Saturday, May 30th) and received significant attention from the Mexican media.
Twitter was also active during the symposium, with the hashtag #microbiota2015 generating over 35,000 impressions.
We hope even more healthcare professionals will join us in 2016 for the next exciting scientific event.
More information will be posted on www.gutmicrobiotaforhealth.com!
Miguel Angel Valdovinos
Prof. Valdovinos is the Director of GI Fellowship Program of the National University of Mexico, Head of the GI Motility Laboratory Department of Gastroenterology, and Director of the WGO Training Center Mexico. Dr. Valdovinos has published over 75 publications in peer reviewed scientific journals and 43 book chapters. He is President of the Mexican Association of Gastroenterology and member of the Mexican Association of Gastrointestinal Endoscopy, Mexican Association of Hepatology, American Gastroenterological Association, American Society of Gastrointestinal Endoscopy, and the National Resarch System in Mexico, among others.
Studies over the last decade have brought new hope that gut microbiome-targeted therapeutics might offer novel treatments for obesity. In this post, we ask whether dietary interventions, prebiotics, probiotics and medication that target the microbiome are useful for weight management.
The 11th Gut Microbiota for Health World Summit focused on emerging gut microbiome-targeted treatments in digestive, immune and cardiometabolic health. This post highlights the major take-aways from the conference and explores how they might impact clinical practice in the foreseeable future.
Following the GMFH 2022 Year at a Glance report, it is time for a flashback in the latest research on cancer microbiome. This post ranges between the epidemiology, etiology and diagnosis of cancer, looking at the role of fungal and bacterial gut microbiome in all three health care branches.